I am a
Home I AM A Search Login

Papers of the Week

2020 Apr 27

J Vasc Surg Venous Lymphat Disord

Results of Polidocanol Endovenous Microfoam in clinical practice.


Kim PS, Elias S, Gasparis A, Labropoulos N
J Vasc Surg Venous Lymphat Disord. 2020 Apr 27.
PMID: 32353594.


Initial Phase III clinical studies with polidocanol endovenous microfoam (PEM) have demonstrated safety and efficacy in the treatment of superficial venous reflux. In those studies, the primary outcome requirement was to assess improvement in symptoms related to superficial venous disease. The goal of this study was to evaluate the efficacy of PEM technology in routine clinical practice, specifically closure rates following treatment.